Lincoln Jimenez, MD
Neurological Surgery · Pensacola, FLNPI 1003011339
Payments from drug & device makers
Across 49 payments — averaging $145.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$6K
- Microvention, Inc.$381
- Medtronic$155
- Johnson & Johnson$144
- Imperative Care, Inc$82
- Aesculap Implant Systems, LLC$41
- plus $211 from 8 others
What the payments were for
- Travel & lodging$5,99284%
- Food & beverage$1,13416%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 26 | $6,113 |
| Microvention, Inc. | 4 | $381 |
| Medtronic | 4 | $155 |
| Johnson & Johnson | 4 | $144 |
| Imperative Care, Inc | 1 | $82 |
| Aesculap Implant Systems, LLC | 1 | $41 |
| GE HealthCare | 1 | $30 |
| Spinal Elements, Inc. | 2 | $29 |
| Qapel Medical Inc | 1 | $28 |
| Surgalign Spine Technologies, Inc. | 1 | $28 |
| Zimmer Biomet | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
| Novocure Inc. | 1 | $25 |
| DJO, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Excelsius Robotics System$1,315
- ExcelsiusGPS Robotic Navigation System$1,175
- RISE-L$1,167
- MARS 3VL Retractor$805
- Excelsius - GPS$450
- ELSA ATP$431
- WEB$344
- MARS Anterior Retractor$158
- MARS Lateral ALIF$153
- 3D Printed Integrated ALIF Spa$129
How this compares
$7,126 in reported general payments places this provider in the 50th percentile of 556 neurological surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 15 | $255 |
| Cyclobenzaprine Hcl | 12 | $150 |
| Pregabalin | 12 | $123 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Pensacola
- Stephen ParkerJacksonville$18.7M
- Ira GoodmanOrlando$10.4M
- Eric PetersonMiami$10.1M
- Brian SnellingBoca Raton$10M
- Kim ManwaringOrlando$5M
- Ricardo HanelJacksonville$3.8M
- Brian HohGainesville$3.7M
- Paul SawinWinter Park$3M
- John MainOcala$2.8M
- Michael WangMiami$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.